Learn about the history of the New Jersey cannabis market prior to the start of the NJ-CRC, shared from the perspective of executive director Jeff Brown.
Episode Notes: Fiscal numbers discussed in this episode may have been updated. To review the most up-to-date statistical information, visit www.nj.gov/cannabis/resources/reports-stats-info. For information on the Medicinal Cannabis Program, visit www.nj.gov/cannabis/medicinalcannabis.
Previous Blog Posts
Grandes éxitos: Celebrando tres años de NJ-CRC y dos años de ventas de canabis recreativo
06/6/2024
Maria Del Cid-Kosso, comisionada de la junta directiva de NJ-CRC, analiza el estado actual de la industria del canabis en Nueva Jersey y celebra el tercer aniversario de NJ-CRC en el primer episodio en español de High Points.
Cannabis and Anxiety
05/20/2024
May is Mental Health Awareness Month and according to the World Health Organization, anxiety is one of the most common mental health disorders worldwide. As cannabis has increasingly gained recognition as a treatment option for various forms of anxiety, it is a qualifying medical condition for New Jersey’s Medicinal Cannabis Program – as is Post-Traumatic Stress Disorder (PTSD). While the federal ban on cannabis currently restricts scientific and medical research, there are some studies that indicate potential benefits for those living with anxiety disorders are promising.
Roots of green: Chronicles of the pre-NJ-CRC era of the NJ cannabis market
05/3/2024
Learn about the history of the New Jersey cannabis market prior to the start of the NJ-CRC, shared from the perspective of Executive Director Jeff Brown.